Neuronetics (STIM) Earnings Date & Reports

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

STIM is expected to report earnings to fall 42.42% to -18 cents per share on May 13

Q1'25

Est.

$-0.19

Q4'24

Missed

by $0.09

Q3'24

Missed

by $0.21

Q2'24

Missed

by $0.06

Q1'24

Beat

by $0.02

The last earnings report on March 04 showed earnings per share of -33 cents, missing the estimate of -23 cents. With 342.25K shares outstanding, the current market capitalization sits at 141.64M.

View a ticker or compare two or three

Compare

STIM